Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Lentiviral vector encoding human coagulation factor IX

EU orphan designation number: EU/3/19/2141   
Active ingredient: Lentiviral vector encoding human coagulation factor IX
Indication: Treatment of haemophilia B
Sponsor: Fondazione Telethon
Via Varese 16b, 00185 Roma, Italia

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/02/2019 Orphan designation EMA/OD/0000002293 (2019)1733 of 26/02/2019